Test Price
2,800 AEDโ Home Collection Available
BAG3 Gene Dilated Cardiomyopathy (Type 1HH) Genetic Test in UAE โ 2800 AED โ DHA Licensed
Executive Summary & Clinical Assurance
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139) with advanced NGS variant calling and orthogonal confirmation.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (available daily from 8 AM to 11 PM) ensuring sample integrity.
- Clinical Guidance: Telephonic post-test clinical guidance with a DHA-licensed consultant medical geneticist to interpret results and discuss actionable next steps.
- Insurance Support: Direct billing verification and pre-authorization assistance via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The BAG3 Gene Dilated Cardiomyopathy (Type 1HH) NGS Test detects pathogenic variants in the BAG3 gene associated with dilated cardiomyopathy type 1HH, a heritable condition causing heart muscle weakness. This test aids cardiologists, researchers, and individuals in confirming diagnosis, assessing familial risk, and guiding precision management.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative (Standard Panel) |
|---|---|---|
| Methodology | NGS with full BAG3 gene coverage, CNV detection, and MLPA backup | Limited exon hotspot sequencing |
| Turnaround Time | 3โ4 weeks (expedited option available) | 6โ8 weeks |
| Precision | >99.9% analytical sensitivity & specificity | ~95% sensitivity; may miss deep intronic variants |
| UAE DHA Compliance | Fully DHA-licensed facility (License No. 1143), ISO 9001:2015 | May lack local accreditation |
| Home Collection | VIP Mobile Phlebotomy & Cold-Chain Home Collection (8 AMโ11 PM) | Lab visit only |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (DHA Registration ID: 9294403), Consultant Medical Genetics, advises: โGenetic testing for BAG3 cardiomyopathy provides critical prognostic information; however, results must be correlated with clinical and family history. A positive variant does not always predict disease severity, and a negative result does not exclude other genetic or acquired cardiomyopathies. Always discuss findings with your cardiologist before altering any management plan.โ
Safety Advisory: Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Individuals unable to provide informed consent (use legally authorized representative); active systemic infection affecting sample quality; unconfirmed family history where pre-test genetic counseling not performed.
- Emergency Red Flags (seek immediate cardiology evaluation): New onset chest pain, syncope, severe dyspnea, palpitations with dizziness, or signs of heart failure (orthopnea, pedal edema) during the testing period.
Patient Consent & Data Privacy
All genetic data handled in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Results stored securely and disclosed only to authorized individuals. Minors require parental consent per Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the purpose of the BAG3 Gene Dilated Cardiomyopathy NGS test, and how does it help me?
This test identifies pathogenic variants in the BAG3 gene that cause dilated cardiomyopathy type 1HH, enabling early diagnosis, family screening, and personalized heart failure management.
2. How is the sample collected, and is the home service reliable for DNA stability?
We provide a hospital-grade cold-chain home collection service (8 AMโ11 PM) using either whole blood, extracted DNA, or a simple finger-prick FTA card that preserves DNA at ambient temperature, ensuring 99.9% integrity for NGS analysis.
3. When will I receive my results, and will a doctor explain them to me?
Results are delivered in 3โ4 weeks with a telephonic post-test consultation by a DHA-licensed consultant medical geneticist who interprets the genetic findings in clinical context and outlines preventive or therapeutic steps.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License Number 1143 and is fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, stored securely in UAE-based servers, and accessed only by authorized personnel. Clinical testing safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | BAG3 Gene Dilated Cardiomyopathy (Type 1HH) Genetic Test โ NGS |
| Price (AED) | 2800 |
| Turnaround Time | 3โ4 weeks (expedited available) |
| Sample Type / Matrix | Whole Blood (peripheral), Extracted DNA, or FTA Card |
| Methodology Used | Next Generation Sequencing (NGS) with CNV detection by MLPA |
| ICD-10-CM Code | I42.0 |
| LOINC Code | 91628-8 |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians